Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients-Reference-Cited by-同舟云学术

Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients

Published:2021-12 Issue: Volume:60 Page:131-137
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Corsi Fabio,Albasini Sara,Sorrentino Luca,Armatura Giulia^ORCID,Carolla Claudia^ORCID,Chiappa Corrado^ORCID,Combi Francesca^ORCID,Curcio Annalisa,Della Valle Angelica^ORCID,Ferrari Guglielmo,Gasparri Maria Luisa^ORCID,Gentilini Oreste,Ghilli Matteo^ORCID,Listorti Chiara^ORCID,Mancini Stefano,Marinello Peter,Meani Francesco^ORCID,Mele Simone^ORCID,Pertusati Anna,Roncella Manuela^ORCID,Rovera Francesca^ORCID,Sgarella Adele,Tazzioli Giovanni^ORCID,Tognali Daniela,Folli Secondo

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference42 articles.

1. De-escalating and escalating treatments for early-stage breast cancer: the st. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017;Curigliano;Ann Oncol,2017

2. Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges;Heil;Ann Oncol,2020

3. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials;Lancet Oncol,2018

4. Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?;Wang-Lopez;Crit Rev Oncol Hematol,2015

5. Kuerer HM, Rauch GM, Krishnamurthy S, et al. A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can Be eliminated following neoadjuvant systemic therapy. Ann Surg.;267(5):946-951.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012);Frontiers in Oncology;2024-05-10

2. A scoping review of web-based, interactive, personalized decision-making tools available to support breast cancer treatment and survivorship care;Journal of Cancer Survivorship;2024-03-28

3. Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?;The Breast;2024-02

4. Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy;Journal of Cancer Research and Clinical Oncology;2023-05-02

5. Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis;2023-04-27